6 курс / Медицинская реабилитация, ЛФК, Спортивная медицина / Эффекты_трансплантации_мононуклеарных_клеток_пуповинной_крови_человека

101

76.Hauptmann, S. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease [Text] / S. Hauptmann, U. Keil, I. Scherping, et al. // Exp Gerontol. – 2006. –

V.41, № 7. – P. 668-673.

77.Hayashi, Y. Alzheimer amyloid protein precursor enhances proliferation of neural stem cells from fetal rat brain [Text] / Y. Hayashi, K. Kashiwagi, J. Ohta, et al. // Biochem Biophys Res Commun. – 1994. – V. 205, № 1. – P. 936-943.

78.Heber, S. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members [Text] / S. Heber,

J.Herms, V. Gajic, et al. // J Neurosci. – 2000. – V. 20, № 21. – P. 7951-7963.

79.Hebert, L. E. Alzheimer disease in the US population: prevalence estimates using the 2000 census [Text] / L. E. Hebert, P. A. Scherr, J. L. Bienias, et al. // Arch Neurol. – 2003. – V. 60, № 8. – P. 1119-1122.

80.Heneka, M. T. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice [Text] / M. T. Heneka, M. Ramanathan,

A.H. Jacobs, et al. // J Neurosci. – 2006. – V. 26, № 5. – P. 1343-1354.

81.Heppner, F. L. Immune attack: the role of inflammation in Alzheimer disease [Text] / F. L. Heppner, R. M. Ransohoff, B. Becher // Nat Rev Neurosci. – 2015. – V. 16, №

6. – P. 358-372.

82.Hickman, S. E. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice [Text] / S. E. Hickman, E. K. Allison, J. El Khoury // J Neurosci. – 2008. – V. 28, № 33. – P. 8354-8360.

83.Hippius, H. The discovery of Alzheimer's disease [Text] / H. Hippius, G. Neundorfer // Dialogues Clin Neurosci. – 2003. – V. 5, № 1. – P. 101-108.

84.Hoke, A. Expression of glial cell line-derived neurotrophic factor family of growth factors in peripheral nerve injury in rats [Text] / A. Hoke, C. Cheng, D. W. Zochodne // Neuroreport. – 2000. – V. 11, № 8. – P. 1651-1654.

85.Hong, S. Complement and microglia mediate early synapse loss in Alzheimer mouse models [Text] / S. Hong, V. F. Beja-Glasser, B. M. Nfonoyim, et al. // Science. – 2016.

– V. 352, № 6286. – P. 712-716.

t.me/medicina_free

102

86.Hung, V. K. Selective astrocytic endothelin-1 overexpression contributes to dementia associated with ischemic stroke by exaggerating astrocyte-derived amyloid secretion [Text] / V. K. Hung, P. K. Yeung, A. K. Lai, et al. // J Cereb Blood Flow Metab. – 2015. – V. 35, №10. – P. 1687-1696.

87.Iannotti, C. A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injury [Text] / C. Iannotti, Y. Ping Zhang,

C.B. Shields, et al. // Exp Neurol. – 2004. – V. 189, № 2. – P. 317-332.

88.Ibanez, C. F. Biology of GDNF and its receptors - Relevance for disorders of the central nervous system [Text] / C. F. Ibanez, J. O. Andressoo // Neurobiol Dis. – 2017.

– V. 97, № Pt B. – P. 80-89.

89.Ingelsson, M. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain [Text] / M. Ingelsson, H. Fukumoto, K. L. Newell, et al. // Neurology. – 2004. – V. 62, № 6. – P. 925-931.

90.Iqbal, K. Tau pathology in Alzheimer disease and other tauopathies [Text] / K. Iqbal,

C.Alonso Adel, S. Chen, et al. // Biochim Biophys Acta. – 2005. – V. 1739, № 2-3. –

P. 198-210.

91.Ishida, N. Periodontitis induced by bacterial infection exacerbates features of Alzheimer's disease in transgenic mice [Text] / N. Ishida, Y. Ishihara, K. Ishida, et al. // NPJ Aging Mech Dis. – 2017. – V. 3. – P. 15.

92.Jefferson, T. Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo [Text] / T. Jefferson, M. Causevic, U. auf dem Keller, et al. // J Biol Chem. – 2011. – V. 286, № 31. – P. 27741-27750.

93.Jonsson, T. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline [Text] / T. Jonsson, J. K. Atwal, S. Steinberg, et al. // Nature. – 2012.

– V. 488, № 7409. – P. 96-99.

94.Jucker, M. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases [Text] / M. Jucker, L. C. Walker // Nature. – 2013. – V. 501, № 7465. – P. 45-51.

t.me/medicina_free

103

95.Kamal, A. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP [Text] / A. Kamal, A. Almenar-Queralt,

J.F. LeBlanc, et al. // Nature. – 2001. – V. 414, № 6864. – P. 643-648.

96.Kamenetz, F. APP processing and synaptic function [Text] / F. Kamenetz, T. Tomita,

H.Hsieh, et al. // Neuron. – 2003. – V. 37, № 6. – P. 925-937.

97.Kaneko, I. Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue [Text] / I. Kaneko, N. Yamada, Y. Sakuraba, et al. // J Neurochem. – 1995. – V. 65, № 6. – P. 2585-2593.

98.Kang, J. The precursor of Alzheimer's disease amyloid A4 protein resembles a cellsurface receptor [Text] / J. Kang, H. G. Lemaire, A. Unterbeck, et al. // Nature. – 1987.

– V. 325, № 6106. – P. 733-736.

99.Karch, C. M. Alzheimer's disease risk genes and mechanisms of disease pathogenesis [Text] / C. M. Karch, A. M. Goate // Biol Psychiatry. – 2015. – V. 77, № 1. – P. 4351.

100.Kayed, R. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis [Text] / R. Kayed, E. Head, J. L. Thompson, et al. // Science. – 2003. – V. 300, № 5618. – P. 486-489.

101.Keller, J. N. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes [Text] / J. N. Keller, R. J. Mark, A. J. Bruce, et al. // Neuroscience. – 1997. – V. 80,

№ 3. – P. 685-696.

102.Kent, S. A. The physiological roles of tau and Abeta: implications for Alzheimer's disease pathology and therapeutics [Text] / S. A. Kent, T. L. Spires-Jones, C. S. Durrant // Acta Neuropathol. – 2020. – V. 140, № 4. – P. 417-447.

103.Klein, S. Truncating mutations in APP cause a distinct neurological phenotype [Text] / S. Klein, A. Goldman, H. Lee, et al. // Ann Neurol. – 2016. – V. 80, № 3. – P. 456460.

104.Krabbe, G. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology [Text] / G. Krabbe, A. Halle, V. Matyash, et al. // PLoS One. – 2013. – V. 8, № 4. – P. e60921.

t.me/medicina_free

104

105.Kraepelin, E. Psychiatrie: ein lehrbuch für studierende und ärzte [Text] / E. Kraepelin

//Barth. – 1913. – V. 3.

106.Krstic, D. Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice [Text] / D. Krstic, A. Madhusudan, J. Doehner, et al. // J Neuroinflammation. – 2012. – V. 9. – P. 151.

107.Krut, J. J. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections [Text] / J. J. Krut, H. Zetterberg, K. Blennow, et al. // J Neurol. – 2013. – V. 260, №

2. – P. 620-626.

108.Kubo, T. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients [Text] / T. Kubo, S. Nishimura, Y. Kumagae, et al.

//J Neurosci Res. – 2002. – V. 70, № 3. – P. 474-483.

109.Kumar, D. K. Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease [Text] / D. K. Kumar, S. H. Choi, K. J. Washicosky, et al. // Sci Transl Med. – 2016. – V. 8, № 340. – P. 340ra372.

110.Kummer, M. P. Truncated and modified amyloid-beta species [Text] / M. P. Kummer, M. T. Heneka // Alzheimers Res Ther. – 2014. – V. 6, № 3. – P. 28.

111.LaFerla, F. M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease [Text] / F. M. LaFerla // Nat Rev Neurosci. – 2002. – V. 3, № 11. – P. 862872.

112.Lane, C. A. Alzheimer's disease [Text] / C. A. Lane, J. Hardy, J. M. Schott // Eur J Neurol. – 2018. – V. 25, № 1. – P. 59-70.

113.Larson, J. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice [Text] / J. Larson, G. Lynch, D. Games, et al. // Brain Res. – 1999. – V. 840, № 1-2. – P. 23-35.

114.Larson, J. Theta-burst LTP [Text] / J. Larson, E. Munkacsy // Brain Res. – 2015. – V. 1621. – P. 38-50.

115.Lazarov, O. All in the Family: How the APPs Regulate Neurogenesis [Text] / O. Lazarov, M. P. Demars // Front Neurosci. – 2012. – V. 6. – P. 81.

t.me/medicina_free

105

116.Ledda, F. GDNF and GFRalpha1 promote formation of neuronal synapses by ligandinduced cell adhesion [Text] / F. Ledda, G. Paratcha, T. Sandoval-Guzman, C.F. Ibanez // Nat Neurosci. – 2007. – V. 10, № 3. – P. 293-300.

117.Ledda, F. GDNF and GFRalpha1 promote formation of neuronal synapses by ligandinduced cell adhesion[Text] / F. Ledda, G. Paratcha, T. Sandoval-Guzman, C.F. Ibanez

//Nat Neurosci. – 2007. – V. 10, № 3. – P. 293-300.

118.Lee, C. Y. The role of microglia in amyloid clearance from the AD brain [Text] / C. Y. Lee, G. E. Landreth // J Neural Transm (Vienna). – 2010. – V. 117, № 8. – P. 949960.

119.Lee, C. K. Gene-expression profile of the ageing brain in mice [Text] / C. K. Lee, R. Weindruch, T. A. Prolla // Nat Genet. – 2000. – V. 25, № 3. – P. 294-297.

120.Lee, M. S. APP processing is regulated by cytoplasmic phosphorylation [Text] / M. S. Lee, S. C. Kao, C. A. Lemere, et al. // J Cell Biol. – 2003. – V. 163, № 1. – P. 8395.

121.Lewis, D. A. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies [Text] / D. A. Lewis, R. A. Sweet // J Clin Invest.

– 2009. – V. 119, № 4. – P. 706-716.

122.Lewis, I. D. Clinical and experimental uses of umbilical cord blood [Text] / I. D. Lewis

//Intern Med J. – 2002. – V. 32, № 12. – P. 601-609.

123.Little, C. S. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice [Text] / C. S. Little, C. J. Hammond, A. MacIntyre, et al. // Neurobiol Aging. – 2004. – V. 25, № 4. – P. 419-429.

124.Little, C. S. Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae [Text] / C. S. Little, T. A. Joyce, C. J. Hammond, et al. // Front Aging Neurosci. – 2014. – V.6. – P. 304.

125.Lopez-Toledano, M. A. Neurogenic effect of beta-amyloid peptide in the development of neural stem cells [Text] / M. A. Lopez-Toledano, M. L. Shelanski // J Neurosci. – 2004. – V. 24, № 23. – P. 5439-5444.

t.me/medicina_free

106

126.Lowery, L. A. The trip of the tip: understanding the growth cone machinery [Text] /

L.A. Lowery, D. Van Vactor // Nat Rev Mol Cell Biol. – 2009. – V. 10, № 5. – P. 332-343.

127.Lu, B. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases [Text] / B. Lu, G. Nagappan, X. Guan, et al. // Nat Rev Neurosci. – 2013. – V. 14, № 6. – P. 401-416.

128.Lu, D. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury [Text] / D. Lu, P. R. Sanberg,

A.Mahmood, et al. // Cell Transplant. – 2002. – V. 11, № 3. – P. 275-281.

129.Lukiw, W. J. Acyclovir or Abeta42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells [Text] / W. J. Lukiw, J. G. Cui, L. Y. Yuan, et al. // Neuroreport. – 2010. – V. 21, № 14. – P. 922-927.

130.Marchetti, C. Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models? [Text] / C. Marchetti, H. Marie // Rev Neurosci.

– 2011. – V. 22, № 4. – P. 373-402.

131.Mark, R. J. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation [Text] / R. J. Mark, Z. Pang, J. W. Geddes, et al. // J Neurosci. – 1997. – V. 17, № 3. – P. 1046-1054.

132.Matsui, T. Expression of APP pathway mRNAs and proteins in Alzheimer's disease [Text] / T. Matsui, M. Ingelsson, H. Fukumoto, et al. // Brain Res. – 2007. – V. 1161.

– P. 116-123.

133.Maurer, K. Auguste D and Alzheimer's disease [Text] / K. Maurer, S. Volk, H. Gerbaldo // The Lancet. – 1997. – V. 349, № 9064. – P. 1546–1549.

134.Mawuenyega, K. G. Decreased clearance of CNS beta-amyloid in Alzheimer's disease [Text] / K. G. Mawuenyega, W. Sigurdson, V. Ovod, et al. // Science. – 2010.

– V. 330, № 6012. – P. 1774.

135.Mayeux, R. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives [Text] / R. Mayeux, R. Ottman, M. X. Tang, et al. // Ann Neurol. – 1993. – V. 33, №

5. – P. 494-501.

t.me/medicina_free

107

136.Mayford, M. Synapses and memory storage [Text] / M. Mayford, S. A. Siegelbaum,

E.R. Kandel // Cold Spring Harb Perspect Biol. – 2012. – V.4, № 6.

137.McShane, R. Memantine for dementia [Text] / R. McShane, A. Areosa Sastre, N. Minakaran // Cochrane Database Syst Rev. – 2006. № 2. – P. CD003154.

138.Messier, C. The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease [Text] / C. Messier, K. Teutenberg // Neural Plast. – 2005. – V. 12, № 4. – P. 311-328.

139.Messing, A. GFAP at 50 [Text] / A. Messing, M. Brenner // ASN Neuro. – 2020. – V. 12. – P. 1759091420949680.

140.Miklossy, J. Bacterial Amyloid and DNA are Important Constituents of Senile Plaques: Further Evidence of the Spirochetal and Biofilm Nature of Senile Plaques [Text] / J. Miklossy // J Alzheimers Dis. – 2016. – V. 53, № 4. – P. 1459-1473.

141.Miller, K. R. The effects of aging, injury and disease on microglial function: a case for cellular senescence [Text] / K. R. Miller, W. J. Streit // Neuron Glia Biol. – 2007.

– V. 3, № 3. – P. 245-253.

142.Montagne, A. Blood-brain barrier breakdown in the aging human hippocampus [Text] / A. Montagne, S. R. Barnes, M. D. Sweeney, et al. // Neuron. – 2015. – V. 85, № 2. –

P.296-302.

143.Morley, J. E. The role of amyloid-beta in the regulation of memory [Text] / J. E. Morley, S. A. Farr // Biochem Pharmacol. – 2014. – V. 88, № 4. – P. 479-485.

144.Mufson, E. J. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications [Text] / E. J. Mufson, S. E. Counts, S. E. Perez, et al. // Expert Rev Neurother. – 2008. – V. 8, № 11. – P. 1703-1718.

145.Mufson, E.J. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications [Text] / E. J. Mufson, S. E. Counts, S. E. Perez, et al. // Expert Rev Neurother. – 2008. – V. 8, № 11. – P. 1703-1718.

146.Mullard, A. Sting of Alzheimer's failures offset by upcoming prevention trials [Text] / A. Mullard // Nat Rev Drug Discov. – 2012. – V. 11, № 9. – P. 657-660.

t.me/medicina_free

108

147.Muller, S. A. Proteomic Substrate Identification for Membrane Proteases in the Brain [Text] / S. A. Muller, S. D. Scilabra, S. F. Lichtenthaler // Front Mol Neurosci. – 2016.

–V. 9. – P. 96.

148.Muller, U. C. Not just amyloid: physiological functions of the amyloid precursor protein family [Text] / U. C. Muller, T. Deller, M. Korte // Nat Rev Neurosci. – 2017.

–V. 18, № 5. – P. 281-298.

149.Mungarro-Menchaca, X. beta-Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine [Text] / X. Mungarro-Menchaca, P. Ferrera, J. Moran, et al. // J Neurosci Res. – 2002.

–V. 68, № 1. – P. 89-96.

150.Na, R. A Systematic Review and Meta-Analysis of Nonpharmacological Interventions for Moderate to Severe Dementia [Text] / R. Na, J. H. Yang, Y. Yeom, et al. // Psychiatry Investig. – 2019. – V. 16, № 5. – P. 325-335.

151.Nagele, R. G. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains [Text] / R. G. Nagele, M. R. D'Andrea, H. Lee, et al. // Brain Res. – 2003. – V. 971, № 2. – P. 197-209.

152.Nakahata, T. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate monoand multipotential hemopoietic progenitors [Text] / T. Nakahata, M. Ogawa // J Clin Invest. – 1982. – V. 70, № 6. – P. 1324-1328.

153.Neefjes, J. Stuck in traffic: an emerging theme in diseases of the nervous system [Text] / J. Neefjes, R. van der Kant // Trends Neurosci. – 2014. – V. 37, № 2. – P. 66-76.

154.Ngandu, T. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial [Text] / T. Ngandu, J. Lehtisalo, A. Solomon, et al. // Lancet. – 2015. – V. 385, № 9984. – P. 2255-2263.

155.Nikolic, W. V. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice [Text] / W. V. Nikolic, H. Hou, T. Town, et al. // Stem Cells Dev. – 2008. – V. 17, № 3. – P. 423439.

t.me/medicina_free

109

156.Norton, S. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data [Text] / S. Norton, F. E. Matthews, D. E. Barnes, et al. // Lancet Neurol. – 2014. – V. 13, № 8. – P. 788-794.

157.Ohshima, M. Evaluations of Intravenous Administration of CD34+ Human Umbilical Cord Blood Cells in a Mouse Model of Neonatal Hypoxic-Ischemic Encephalopathy [Text] / M. Ohshima, A. Taguchi, Y. Sato, et al. // Dev Neurosci. – 2016. – V. 38, №

5.– P. 331-341.

158.Orgeta, V. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis [Text] / V. Orgeta, A. Qazi, A. Spector, et al. // Br J Psychiatry. – 2015. – V. 207, № 4. – P. 293-298.

159.Ortiz-Sanz, C. Early Effects of Abeta Oligomers on Dendritic Spine Dynamics and Arborization in Hippocampal Neurons [Text] / C. Ortiz-Sanz, A. Gaminde-Blasco, J. Valero, et al. // Front Synaptic Neurosci. – 2020. – V. 12. – P. 2.

160.Paielli, D. L. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse [Text] / D. L. Paielli, M. S. Wing, K. R. Rogulski, et al. // Mol Ther. – 2000. – V. 1, № 3. – P. 263-274.

161.Paris, D. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis [Text] / D. Paris, N. Patel, A. DelleDonne, et al. // Neurosci Lett. – 2004. – V. 366, №

1.– P. 80-85.

162.Parkhurst, C. N. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor [Text] / C. N. Parkhurst, G. Yang, I. Ninan, et al. // Cell. – 2013. – V. 155, № 7. – P. 1596-1609.

163.Pastorino, L. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production [Text] / L. Pastorino, A. Sun, P. J. Lu, et al. // Nature. – 2006. – V. 440, № 7083. – P. 528-534.

164.Petukhova, E. O. Effects of Transplanted Umbilical Cord Blood Mononuclear Cells

Overexpressing GDNF on Spatial Memory and Hippocampal Synaptic Proteins in a

Mouse Model of Alzheimer's Disease [Text] / E. O. Petukhova, Y. O.

t.me/medicina_free

110

Mukhamedshina, I. I. Salafutdinov, et al. // J Alzheimers Dis. – 2019. – V. 69, № 2. –

P.443-453.

165.Pisa, D. Direct visualization of fungal infection in brains from patients with Alzheimer's disease [Text] / D. Pisa, R. Alonso, A. Juarranz, et al. // J Alzheimers Dis.

– 2015. – V. 43, № 2. – P. 613-624.

166.Puig, K. L. Expression and function of APP and its metabolites outside the central nervous system [Text] / K. L. Puig, C. K. Combs // Exp Gerontol. – 2013. – V. 48, №

7. – P. 608-611.

167.Quintela-Lopez, T. Abeta oligomers promote oligodendrocyte differentiation and maturation via integrin beta1 and Fyn kinase signaling [Text] / T. Quintela-Lopez, C. Ortiz-Sanz, M. P. Serrano-Regal, et al. // Cell Death Dis. – 2019. – V. 10, № 6. – P. 445.

168.Reiman, E. M. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study [Text] / E. M. Reiman, Y. T. Quiroz, A. S. Fleisher, et al. // Lancet Neurol. – 2012. – V. 11, № 12. – P. 1048-1056.

169.Repetto, E. BACE1 overexpression regulates amyloid precursor protein cleavage and interaction with the ShcA adapter [Text] / E. Repetto, C. Russo, V. Venezia, et al. // Ann N Y Acad Sci. – 2004. – V. 1030. – P. 330-338.

170.Revilla, S. Lenti-GDNF gene therapy protects against Alzheimer's disease-like neuropathology in 3xTg-AD mice and MC65 cells [Text] / S. Revilla, S. Ursulet, M.

J.Alvarez-Lopez, et al. // CNS Neurosci Ther. – 2014. – V. 20, № 11. – P. 961-972.

171.Richetin, K. Genetic manipulation of adult-born hippocampal neurons rescues memory in a mouse model of Alzheimer's disease [Text] / K. Richetin, C. Leclerc, N. Toni, et al. // Brain. – 2015. – V. 138, № Pt 2. – P. 440-455.

172.Rocha, S. M. Astrocyte-derived GDNF is a potent inhibitor of microglial activation [Text] / S. M. Rocha, A. C. Cristovao, F. L. Campos, et al. // Neurobiol Dis. – 2012. –

V.47, № 3. – P. 407-415.

173.Rodda, J. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review

t.me/medicina_free